864847

Hikma Pharmaceuticals USA, Inc. — FEI 2250102

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 26, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Eatontown, NJ (United States)

Citations

IDCFRDescription
202821 CFR 211.192Extent of discrepancy, failure investigations